Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistanceAlbert J. van Hell, Marcel Verheij, Manuel N. Melo et al.|Scientific Reports|2013Cited by 24
Improving Intracellular Doxorubicin Delivery Through Nanoliposomes Equipped with Selective Tumor Cell Membrane Permeabilizing Short-Chain SphingolipidsLília R. Cordeiro Pedrosa, Gerben A. Koning, Wiggert A. van Cappellen et al.|Pharmaceutical Research|2013Cited by 19
Short-Chain Glycoceramides Promote Intracellular Mitoxantrone Delivery from Novel Nanoliposomes into Breast Cancer CellsLília R. Cordeiro Pedrosa, Gerben A. Koning, Timo L.M. ten Hagen et al.|Pharmaceutical Research|2014Cited by 16
A Novel Combined Approach of Short-Chain Sphingolipids and Thermosensitive Liposomes for Improved Drug Delivery to Tumor CellsAzadeh Haeri, Gerben A. Koning, Lília R. Cordeiro Pedrosa et al.|Journal of Biomedical Nanotechnology|2016Cited by 12
Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft modelLília R. Cordeiro Pedrosa, Gerben A. Koning, Olaf van Tellingen et al.|European Journal of Pharmaceutics and Biopharmaceutics|2015Cited by 11